Long-term outcomes of blue light laser therapy for epistaxis in patients with hereditary hemorrhagic telangiectasia within a multimodal treatment concept

URN to cite this document:: urn:nbn:de:bvb:355-epub-785081
DOI to cite this document:: 10.5283/epub.78508

Heiß, Christina

; Bohr, Christopher ; Kühnel, Thomas S. ; Müller, Karolina ; Zeman, Florian ; Andorfer, Kornelia E. C.

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 26 Jan 2026 12:15

Alternative links to fulltext:DOI Publisher

This publication is part of the DEAL contract with Springer.

Details

Preview

Export bibliographical data

Abstract

Purpose: Hereditary hemorrhagic telangiectasia (HHT) is a genetically inherited vascular disorder transmitted in an autosomal dominant manner. It is defined by the presence of arteriovenous malformations in the nasal mucosa, resulting in severe recurrent epistaxis. This study investigates the long-term efficacy and safety of blue light laser therapy for managing epistaxis in patients with ...